These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1726683)

  • 1. Inosine pranobex in the treatment of HIV infection: a review.
    De Simone C; Famularo G; Tzantzoglou S; Moretti S; Jirillo E
    Int J Immunopharmacol; 1991; 13 Suppl 1():19-27. PubMed ID: 1726683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of zidovudine and concomitant inosine-pranobex in AIDS patients.
    De Simone C; Ferrazzi M; Bitonti F; Falciano M; Tzantzoglou S; Delia S; Sorice F
    Immunopharmacol Immunotoxicol; 1988; 10(4):437-41. PubMed ID: 2469710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoprinosine (inosine pranobex BAN, INPX) in the treatment of AIDS and other acquired immunodeficiencies of clinical importance.
    Glasky AJ; Gordon JF
    Cancer Detect Prev Suppl; 1987; 1():597-609. PubMed ID: 2446760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunological assessment in HIV+ subjects receiving inosine-pranobex. A randomised, multicentric study.
    De Simone C; Albertini F; Almaviva M; Angarano G; Chiodo F; Costigliola P; Delia S; Ferlini A; Gritti F; Mazzarello G
    Med Oncol Tumor Pharmacother; 1989; 6(1):63-7. PubMed ID: 2471025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inosine pranobex and zidovudine metabolism.
    De Simone C; Tzantzoglou S; Vullo V; Catania S; Trinchieri V
    Lancet; 1989 Oct; 2(8669):977. PubMed ID: 2477658
    [No Abstract]   [Full Text] [Related]  

  • 6. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.
    Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO; Nielsen JO
    N Engl J Med; 1990 Jun; 322(25):1757-63. PubMed ID: 1693173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inosine pranobex--is a single positive trial enough?
    Kweder SL; Schnur RA; Cooper EC
    N Engl J Med; 1990 Jun; 322(25):1807-9. PubMed ID: 1693175
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind clinical trial of the effects of inosine pranobex in immunodepressed patients with prolonged generalized lymphadenopathy.
    Wallace JI; Bekesi JG
    Clin Immunol Immunopathol; 1986 Apr; 39(1):179-86. PubMed ID: 2419019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inosine pranobex in the combination therapy of HIV infection.
    De Simone C; Famularo G; Giacomelli R; Tzantzoglou S
    Pharmacol Res; 1992 Sep; 26 Suppl 2():60-1. PubMed ID: 1384023
    [No Abstract]   [Full Text] [Related]  

  • 10. ACTH--inosine pranobex in the treatment of AIDS. Encouraging results.
    Addo E; McFarlane H; Parsad K
    West Indian Med J; 1989 Sep; 38(3):142-7. PubMed ID: 2482585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for a combined use of antiretroviral and immunomodulatory therapies in HIV infection.
    Touraine JL; Sanhadji K; Zerhouni B; Livrozet JM
    Int J Immunopharmacol; 1991; 13 Suppl 1():43-8. PubMed ID: 1726684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the antiallergic component of inosine pranobex (Inosiplex, Isoprinosine).
    Schmutzler W; Neukirch B; Ziesche R
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):244-6. PubMed ID: 2468618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course.
    Beran J; Špajdel M; Slíva J
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases.
    Sliva J; Pantzartzi CN; Votava M
    Adv Ther; 2019 Aug; 36(8):1878-1905. PubMed ID: 31168764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inosine pranobex for preventing AIDS in patients with HIV infection.
    Forthal DN
    N Engl J Med; 1991 Feb; 324(7):491-2. PubMed ID: 1703281
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis.
    Brzeski M; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1990 May; 49(5):293-5. PubMed ID: 1693065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Campoli-Richards DM; Sorkin EM; Heel RC
    Drugs; 1986 Nov; 32(5):383-424. PubMed ID: 2431857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inosine pranobex-BAN increases the resistance to the challenge with cells or cell-free fluid from Yoshida ascites tumor.
    Fimiani V; Cavallaro A; Falliti G; Amato A
    Chemioterapia; 1986 Apr; 5(2):128-33. PubMed ID: 2423256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of inosine pranobex oral therapy in subclinical human papillomavirus infection of the vulva: a randomized double-blinded placebo controlled study.
    Tay SK
    Int J STD AIDS; 1996 Jul; 7(4):276-80. PubMed ID: 8876359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients.
    You Y; Wang L; Li Y; Wang Q; Cao S; Tu Y; Li S; Bai L; Lu J; Wei Z; Chen W; Hao F
    J Dermatol; 2015 Jun; 42(6):596-601. PubMed ID: 25819042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.